Ingenol-3-angelate
CAS: 75567-37-2
Ref. 3D-FI29384
1mg | A consultar | ||
2mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar |
Información del producto
- Ingenol mebutatePEP 005
- 1H-2,8a-Methanocyclopenta[a]cyclopropa[e]cyclodecene, 2-butenoic acid deriv.
- 2-Butenoic acid, 2-methyl-, (1aR,2S,5R,5aS,6S,8aS,9R,10aR)-1a,2,5,5a,6,9,10,10a-octahydro-5,5a-dihydroxy-4-(hydroxymethyl)-1,1,7,9-tetramethyl-11-oxo-1H-2,8a-methanocyclopenta[a]cyclopropa[e]cyclodecen-6-yl ester, (2Z)-
- 2-Butenoic acid, 2-methyl-, 1a,2,5,5a,6,9,10,10a-octahydro-5,5a-dihydroxy-4-(hydroxymethyl)-1,1,7,9-tetramethyl-11-oxo-1H-2,8a-methanocyclopenta[a]cyclopropa[e]cyclodecen-6-yl ester, [1aR-[1aα,2β,5β,5aβ,6β(Z),8aα,9α,10aα]]-
- 3-Angeloylingenol
- Aids-416619
- Aids416619
- Euphorbia factor An<sub>1</sub>
- Euphorbia factor H<sub>1</sub>
- I3A
- Ver más sinónimos
- Ingenol 3-angelate
- Ingenol 3-mebutate
- Ingenol mebutate
- Pep 005
- Picato
- Euphorbia factor An1
Ingenol-3-angelate (ING) is a natural compound that induces apoptosis in cancer cells by inhibiting mitochondrial membrane potential and the production of ATP. It also has been shown to be an active antiretroviral therapy that inhibits HIV replication in T cells. Ingenol-3-angelate has significant cytotoxicity against k562 cells, which can be enhanced by laser ablation. The drug is metabolized to mebutate, which is the only known active form of ING. Mebutate binds to the polymerase chain reaction enzyme DNA polymerase and prevents its activity, thus inhibiting DNA synthesis and replication. Ingenol-3-angelate also has drug interactions with other drugs such as cyclosporin A and tacrolimus, which inhibit or induce cytochrome P450 enzymes.
Propiedades químicas
Consulta técnica sobre: 3D-FI29384 Ingenol-3-angelate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.